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1. INTRODUCTION 
It was noted that all cultured cells require trans- 
ferrin for optimal growth in a serum-free medium 
[I]. In addition there is evidence indicating the ex- 
istence of transferrin receptors in almost all the 
human cell lines grown in vitro [2-131. 
Heme is known to play an important role in 
mammalian cells: (1) it is a structural component 
of hemoglobin; (2) it regulates the expression of 
messenger RNA at the translational level [ 141; (3) 
it affects the rate of the transcription of the globin 
mRNA [15]; and (4) it decreases the proteolysis of 
abnormal proteins in erythroid cells [16]. In addi- 
tion, previous studies have shown that hemin reg- 
ulates iron incorporation into protoporphyrin [ 171. 
More particularly, the addition of hemin to retic- 
ulocytes reduces the iron uptake [IS], while the in- 
cubation of reticulocytes with heme inhibitors in- 
creases the Fe uptake [ 191. 
This prompted us to investigate the effect of the 
hemin on the expression of transferrin receptors in 
several human hematopoietic cell lines. The results 
have shown that hemin constantly decreased the 
binding of transferrin to the cells grown in vitro 
without affecting the affinity of transferrin for its 
receptor. 
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2. MATERIALS AND METHODS 
2.1. Culture 
Four different human hematopoietic cell lines 
were studied: K 562 [20], HL-60 [21], Raji [22] and 
CCRF-CEM [23]. The conditions of culture were 
previously reported [24]. To investigate the effect 
of hemin, K 562 was incubated for 4 days in the 
presence of 100 PM hemin (Sigma, USA); HL-60, 
Raji and CCRF-CEM were grown in the presence 
of 50 PM hemin in order to not affect cell pro- 
liferation or viability. Under these conditions of 
culture, hemin did not affect the growth rate of the 
cell lines. 
2.2. Radiolabelling of transferrin 
Purified human transferrin was obtained from 
Sigma (USA). It was conjugated with 125I by the 
solid phase lactoperoxidase method (New Eng- 
land, Radio iodination system). 
2.3. Radio-iodinated transferrin binding assays 
The binding conditions were performed in the 
conditions previously reported [24]. Briefly, 1 X 106 
cells were incubated for 30 min at 20°C in the 
presence of a constant amount of *251-Trf (50 ng) 
and in the presence of increasing amounts of un- 
labelled transferrin (from 50 ng to 10 pg). 
2.4. Immunojluorescence labelling 
The cells were washed 3 times with Hanks’ sali- 
ne solution and incubated for 30 min in a I:500 or 
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1:lOOO concentration of B3/25 monoclonal anti- 
body [25,26]. After three additional washes, the 
cells were incubated with F(ab’);? rabbit anti- 
mouse IgG conjugated with fluorescein for 30 min. 
The cells were then examined under a Zeiss micro- 
scope equipped for fluorescence and the percen- 
tage of fluorescent cells was determined. 
2.5. Geljltration 
K 562 cells were dissolved in PBS 10 mM (pH 
7.40) containing 1% Triton X-100, phenylmethan- 
sulphonylfluoride (PMSF) at 1 mM. After incuba- 
tion at 4°C for 15 min, the sample was centrifuged 
for 30 min at 13 000 x g. The supematant was 
mixed with a saturating amount of t251-Transfer- 
rin, incubated at 37°C for 15 min and then chro- 
matographed on a column (1 x 40 cm) of Sepha- 
dex G-200 (Superfine, Pharmacia, Uppsala, 
Sweden) equilibrated with 0.1 M Tris-citrate (pH 
5.0) containing Triton X- 100 0.1%. 
2.6. Solubilized transferrin receptor assay 
A simple assay was devised to measure sol- 
ubilized transferrin receptor activity. It is based on 
a difference in solubility of free and transferrin 
bound receptors in polyethylene glycol (PEG). 
Dissolved receptors (Triton X-100 1%) were incu- 
bated in a total volume of 0.2 ml for 30 min at 
37°C in a 0.1 M citrate-Tris buffer solution (pH 
5.0) containing 0.1% bovine serum albumin (BSA), 
0.1% Triton X- 100 and 5 ng of 1*51-transferrin. The 
receptor transferrin complex was precipitated with 
0.8 ml of PEG solution (12% w/v) in 0.1 M citr- 
ate-Tris buffer (pH 5.0) containing BSA O.l%, 
Triton X-100 0.1% and the carrier human gamma- 
globulin 0.1%. The tubes were placed in an ice- 
bath for 30 min and then centrifuged at 13 000 x g 
for 15 min at 4°C. The supematant and the precip- 
itate were tested for radioactivity. Co-precipitation 
of free transferrin was measured by omitting the 
receptor from the tubes while non specific binding 
of transferrin was determined by pre-incubating 
the samples with 1 mg of non-radioactive transfer- 
rin before adding the radioactive transferrin. 
3. RESULTS 
3.1. Transferrin binding to four human cell lines 
after hemin induction 
The results of the binding of t*51-transferrin to 
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Fig.1. Scatchard plot of bound transferrin against the 
ratio of bound to free lingand cells reacted in competi- 
tive binding assays with a constant amount of 1251-trans- 
ferrin (50 ng) and increasing amounts of ligand (2 ng- 
10 pg). The average number of receptor sites was 
estimated from the X intercept. 
four hematopoietic cell lines have constantly 
shown that 4 days after hemin addition to the cul- 
tures, transferrin binding was markedly reduced 
with respect o the control (table 1). The decrease 
of t*sI-Trf binding induced by hemin was dose de- 
pendent (table 2). At all the concentrations tested 
hemin did not affect the rate of growth of the cells. 
In order to investigate the time required for hemin 
to affect the transferrin binding, we incubated the 
cells with hemin and then we investigated transfer- 
t-in binding at various times. Transferrin binding 
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Table I 
Effect of hemin on ‘251-Trf binding in human hematopoietic cell lines 
Control 
‘251-Trf bound 
(ng/ IOkells) 
Hemin 
‘251-Trf bound 
(ng/ lo6 cells) 
K 562 17 1.3 x 10 -12 4 1.4x 10 -12 
HI 60 20 1.5 x 10 -12 8 1.4x 10 -12 
Raji 3.5 1.5x 10 -12 2 1.7x 10 -12 
CCRF-CEM 9 1.3 x 10 -12 4 1.7x 10 -12 
The difference between the ng of Trf bound in the control and in samples treated 
with hemin was significant (t = 4.89, P > 0.005); in contrast, the constant of af- 
finity was not significantly different in the control and in TPA treated cells 
(t = 0.83, P > 0.4) 
began to decrease as early as 10 hours after in- did not directly affect the binding of transferrin to 
cubation in the presence of hemin (table 3). the cells (data not shown). 
The affinity of receptors was examined by 
means of competitive binding experiments and the 
results were expressed in the form of Scatchard 
plots [27]. The results concerning HL-60 cell line 
are shown in the fig. 1. 
The effect of hemin on the binding of transferrin 
can not be dependent on a decreased rate of cell 
growth since hemin did not inhibit the cellular 
proliferation and the incorporation of thymidine 
as we have previously shown [28,29]. 
The affinity of binding (Z&r) was not signifi- 
cantly modified by hemin induction (table 1). In 
contrast, the number of transferrin receptors sig- 
nificantly decreased after hemin induction (table 
1). The addition of hemin to the binding mixture 
3.2. Expression of transferrin receptor defined by 
immunojluorescence labelling using a B3/25 
monoclonal antibody 
The cellular expression of the transferrin recep- 
Table 2 
Effect of increasing concentration of hemin on trans- 
ferrin binding 
Hemin ‘251-Transferrin bound 
(PM) (% of control) 
0 100 
5 90 
10 85 
25 70 
50 45 
HL-60 cells were grown for three days in the presence of 
increasing concentrations of hemin and ‘z51-Trf binding 
was then investigated 
Fig.2. Gel filtration on G-200 Sephadex of a solubilized 
cellular sample (K 562 cells) preincubated in the 
presence of an excess of ‘251-Trf. 
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Table 3 
Kinetics of the effect of hemin on the binding of 1251- 
transferrin 
Time (h) after t*sI-Trf binding 
hemin addition (% of the control) 
0 100 
1 105 
2 102 
3 98 
10 78 
20 75 
40 60 
50 PM hemin was added to 50 ml of 2 x 105/ml HL-60 
cells and the t*sI-transferrin binding was investigated at 
different times after hemin addition 
Table 4 
Investigation of transferrin receptor by immuno- 
fluorescence 
Cell 
line 
Addition to 
the medium 
% Labelled 
cells 
HL 60 None 100 
HL 60 Hemin, 0.1 mM 49 
K 562 None 88 
K 562 Hemin, 0.1 mM 63 
Transferrin receptor expression was investigated by im- 
munofluorescence labelling using B3/25 monoclonal 
antibody. The difference between the number of cells 
labelled by B3/25 antibody in the control and in hemin 
treated cells was significant (t = 3.5, P > 0.1) 
Table 5 
Investigation of solubilized transferrin receptors 
expression by PEG assay 
K 562 HL 60 
Control Hemin Control Hemin 
t*SI-Trf binding 
(pg/mg protein) o’3 
0.17 0.39 0.19 
The difference in t*sI-transferrin binding between the 
control and hemin treated cells was significant 
(t = 4.7, P > 0.05) 
tor was investigated by immunofluorescence using 
B3/25, a monoclonal antibody which specifically 
recognizes the receptor for transferrin [3 1,321. 
Hemin decreased the proportion of the cells la- 
belled by this antibody (table 4). 
3.3. Transferrin receptor assay on solubilized mem- 
branes 
The above results could be the consequence 
either of a true decrease of transferrin receptors or 
of their exposure to the membrane. In con- 
sequence, we have measured the transferrin recep- 
tor on dissolved membrane samples. In order to 
perform this assay we have complexed 1*51-trans- 
ferrin with cell samples dissolved in Triton X-100 
(1%) and then precipitated the transferrin receptor 
complex in 12% PEG solution. Under our experi- 
mental conditions, transferrin forms a complex 
with its receptor as shown by gel filtration experi- 
ments (fig.2). 
The PEG assay has shown that cells grown in 
the presence of hemin exhibit a lower amount of 
transferrin receptor with respect to those grown 
without hemin (table 3). 
4. DISCUSSION 
Previous experiments [24] have shown that 
hemin regulates the expression of the transferrin 
receptor on the K 562 leukemic cell line. Notably, 
the addition of hemin to the culture medium re- 
sulted in a reduction of receptors for transferrin on 
the surface of K 562 cells. Our experiments extend 
this observation to other human, non-erythroid, 
hematopoietic ell lines. 
Similarly to K 562, after hemin addition, there 
was a significant and constant reduction of the 
number of transferrin binding sites per cell without 
any modification of the affinity of binding, exam- 
ined by means of binding competition experi- 
ments. The action of hemin on the binding of 
transferrin to the cells was dose dependent. Fur- 
thermore, hemin induced a reduction of the pro- 
portion of cells exhibiting the transferrin receptor 
as investigated by immunofluorescence labelling 
with B3/25 monoclonal antibody [25,26]. 
In order to rule out that the action of hemin 
merely consists in modifying the accessibility of 
the transferrin binding sites on the membrane, 
without reducing their real number, we measured 
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the transferrin binding on solubilized membrane 
samples. In these experiments hemin elicited a re- 
duction of transferrin binding sites comparable to 
that observed incubating intact cells with 1251- 
transferrin. These results afford evidence that 
hemin acts by reducing the real number of trans- 
ferrin receptors present on the cell surface. 
Thus, the proliferation status [30-321 and hemin 
are the only known factors that regulate the ex- 
pression of transferrin receptors. Furthermore, 
previous studies have shown that brief incubations 
in the presence of hemin inhibit iron uptake by re- 
ticulocytes [ 18,191 and that this phenomenon could 
be related to an inhibition of iron release from 
transferrin and not to a reduction in transferrin 
binding to the cells [18,19]. Our findings may 
therefore indicate the presence of another mecha- 
nism by which heme regulates the uptake of iron 
by the cells, i.e. via the number of transferrin re- 
ceptors. 
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